Nathan D Jayne
Overview
Explore the profile of Nathan D Jayne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eastburn D, White K, Jayne N, Camiolo S, Montis G, Ha S, et al.
Sci Rep
. 2024 Dec;
14(1):31285.
PMID: 39732835
We report the development and performance of a novel genomics platform, TempO-LINC, for conducting high-throughput transcriptomic analysis on single cells and nuclei. TempO-LINC works by adding cell-identifying molecular barcodes onto...
2.
Eastburn D, White K, Jayne N, Camiolo S, Montis G, Ha S, et al.
bioRxiv
. 2024 Aug;
PMID: 39149288
We report the development and performance of a novel genomics platform, TempO-LINC, for conducting high-throughput transcriptomic analysis on single cells and nuclei. TempO-LINC works by adding cell-identifying molecular barcodes onto...
3.
Jayne N, Liang Z, Lim D, Chen P, Diaz C, Arimoto K, et al.
Blood Adv
. 2024 Mar;
8(10):2410-2423.
PMID: 38513139
The transcription factor RUNX1 is a master regulator of hematopoiesis and is frequently mutated in myeloid malignancies. Mutations in its runt homology domain (RHD) frequently disrupt DNA binding and result...
4.
Davis A, Johnson D, Zheng D, Wang R, Jayne N, Liu M, et al.
Blood
. 2021 Sep;
139(3):424-438.
PMID: 34482400
Posttranscriptional regulation has emerged as a driver for leukemia development and an avenue for therapeutic targeting. Among posttranscriptional processes, alternative polyadenylation (APA) is globally dysregulated across cancer types. However, limited...
5.
Davis A, Einstein J, Zheng D, Jayne N, Fu X, Tian B, et al.
Blood Adv
. 2021 Mar;
5(5):1310-1323.
PMID: 33656539
The proper balance of hematopoietic stem cell (HSC) self-renewal and differentiation is critical for normal hematopoiesis and is disrupted in hematologic malignancy. Among regulators of HSC fate, transcription factors have...